[-] Show simple item record

dc.contributor.authorCerami, Anthonyeng
dc.contributor.corporatenameStadler Genetics Symposium (8th : 1976 : Columbia, Missouri)eng
dc.date.issued1976eng
dc.description.abstractThe genetic diseases of man constitute a unique challenge to the medical scientist. For the past several years our laboratory has been developing new drugs for two of the more common genetic diseases - sickle cell anemia and thalassemia. The status of the development of sodium cyanate as the first chemometallactic agent for the treatment of sickle cell anemia and the development of new iron chelating agents for the treatment of iron overload in patients with thalassemia are discussed.eng
dc.description.statementofresponsibilityANTHONY CERAMI, The Rockefeller University, New York , New York.eng
dc.identifier.urihttps://hdl.handle.net/10355/66580
dc.languageEnglisheng
dc.publisherUniversity of Missouri, Agricultural Experiment Stationeng
dc.titleThe development of new drugs for genetic diseaseseng
dc.typeChaptereng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record